Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 10:22AM ET
0.5000
Dollar change
+0.0150
Percentage change
3.09
%
Index- P/E- EPS (ttm)-4.54 Insider Own7.38% Shs Outstand4.31M Perf Week-14.54%
Market Cap2.15M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float4.00M Perf Month-22.84%
Income-12.54M PEG- EPS next Q- Inst Own6.09% Short Float0.36% Perf Quarter-10.95%
Sales0.00M P/S- EPS this Y- Inst Trans-3.89% Short Ratio0.13 Perf Half Y-29.68%
Book/sh1.34 P/B0.37 EPS next Y- ROA-118.12% Short Interest0.01M Perf Year-75.49%
Cash/sh1.37 P/C0.37 EPS next 5Y- ROE-160.07% 52W Range0.43 - 2.68 Perf YTD-23.08%
Dividend Est.- P/FCF- EPS past 5Y64.97% ROI-237.22% 52W High-81.34% Beta1.00
Dividend TTM- Quick Ratio5.02 Sales past 5Y-7.25% Gross Margin- 52W Low16.20% ATR (14)0.08
Dividend Ex-Date- Current Ratio5.02 EPS Y/Y TTM40.18% Oper. Margin0.00% RSI (14)37.23 Volatility24.07% 13.71%
Employees2 Debt/Eq0.05 Sales Y/Y TTM- Profit Margin- Recom3.00 Target Price3.25
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q92.08% Payout- Rel Volume1.33 Prev Close0.49
Sales Surprise- EPS Surprise- Sales Q/Q- EarningsMar 22 AMC Avg Volume113.44K Price0.50
SMA20-19.66% SMA50-15.17% SMA200-36.81% Trades Volume27,312 Change3.09%
Date Action Analyst Rating Change Price Target Change
Apr-27-20Initiated Ladenburg Thalmann Buy $3.80
Mar-22-24 09:52PM
04:34PM
04:05PM
Feb-22-24 08:00AM
Jan-16-24 08:00AM
08:30AM Loading…
Jan-03-24 08:30AM
Nov-10-23 05:03AM
Nov-07-23 08:30AM
Aug-10-23 05:10PM
04:05PM
Aug-09-23 07:39AM
Aug-08-23 04:05PM
Jul-11-23 09:00AM
08:30AM
Jun-12-23 08:00AM
04:05PM Loading…
May-16-23 04:05PM
May-12-23 08:00AM
May-11-23 08:20AM
08:00AM
May-09-23 08:00AM
07:34AM
May-01-23 08:30AM
Apr-20-23 08:30AM
Apr-04-23 04:02PM
12:00PM
Mar-27-23 08:30AM
Mar-15-23 11:00AM
Mar-07-23 08:00AM
Feb-16-23 08:30AM
Jan-27-23 08:30AM
08:30AM Loading…
Jan-19-23 08:30AM
Jan-05-23 08:00AM
Dec-13-22 08:01AM
08:00AM
Dec-08-22 08:00AM
Dec-01-22 08:00AM
Nov-10-22 08:30AM
Nov-03-22 09:57AM
Oct-27-22 08:30AM
Oct-19-22 08:30AM
Oct-18-22 08:30AM
Oct-14-22 08:43AM
Sep-20-22 12:00PM
Sep-13-22 08:00AM
Aug-22-22 08:30AM
Aug-08-22 08:30AM
Aug-04-22 08:30AM
Aug-02-22 08:30AM
Jul-29-22 09:15AM
Jun-09-22 07:33AM
May-18-22 04:10PM
May-12-22 04:05PM
May-11-22 04:05PM
May-05-22 07:30AM
Apr-22-22 08:30AM
Mar-10-22 04:05PM
Mar-03-22 07:31AM
Feb-17-22 08:01AM
Feb-15-22 09:00AM
Feb-08-22 08:00AM
Feb-03-22 07:30AM
Jan-14-22 01:52PM
Jan-13-22 07:00AM
Jan-06-22 12:45PM
Dec-29-21 08:03AM
Dec-20-21 08:35AM
Dec-15-21 08:31AM
Dec-14-21 08:35AM
Nov-29-21 08:01AM
Nov-04-21 04:05PM
Oct-28-21 03:06PM
Oct-26-21 08:01AM
Oct-07-21 09:05AM
Oct-05-21 08:01AM
Sep-30-21 04:35PM
Sep-28-21 07:01AM
Sep-27-21 08:03AM
Sep-22-21 07:33AM
Sep-20-21 08:35AM
07:33AM
Sep-15-21 08:03AM
Sep-10-21 08:35AM
Sep-08-21 08:13AM
Aug-12-21 02:00PM
09:00AM
Aug-10-21 06:16AM
Aug-05-21 07:32AM
Jul-29-21 07:33AM
Jul-14-21 08:05AM
Jul-13-21 07:33AM
Jul-09-21 07:33AM
Jun-17-21 08:03AM
Jun-15-21 07:30AM
Jun-10-21 01:30PM
Jun-07-21 07:35AM
May-19-21 05:01PM
May-12-21 04:05PM
02:45PM
May-05-21 07:05AM
Apr-29-21 07:30AM
Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in the development of treatments for cancers with high, unmet medical need. Its pipeline includes SP-3164, a targeted protein degrader and seclidemstat (SP-2577), a targeted protein inhibitor. The company was founded in February 2014 and is headquartered in Houston, TX.